Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -0.73% | 158.71 | 0.0% | $1286.08m | |
| AMGN | Amgen, Inc. | 0.00% | 255.13 | 1.3% | $694.68m | |
| NVAX | Novavax, Inc. | 0.95% | 204.00 | 80.0% | $561.76m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | 0.00% | 8.03 | 0.7% | $561.33m | |
| ILMN | Illumina, Inc. | 0.00% | 401.96 | 3.5% | $517.94m | |
| GILD | Gilead Sciences, Inc. | 0.00% | 65.77 | 1.0% | $463.29m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.00% | 494.64 | 2.7% | $449.68m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.00% | 221.10 | 1.9% | $383.88m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.00% | 157.54 | 2.0% | $298.86m | |
| BNTX | BioNTech SE | -0.63% | 139.84 | 0.0% | $264.71m | |
| BIIB | Biogen, Inc. | 0.00% | 270.45 | 1.7% | $264.46m | |
| EXAS | EXACT Sciences Corp. | 0.00% | 130.52 | 18.4% | $192.20m | |
| NBIX | Neurocrine Biosciences, Inc. | 0.00% | 95.00 | 4.9% | $177.73m | |
| CRSP | CRISPR Therapeutics AG | -0.13% | 123.69 | 0.6% | $174.27m | |
| SGEN | Seagen Inc. | 0.00% | 149.64 | 5.8% | $153.69m |
Company Profile
Aevi Genomic Medicine focuses on translating genetic discoveries into novel therapies. It is dedicated to unlocking the potential of genomic medicine to translate genetic discoveries into novel therapies. Driven by a commitment to patients with pediatric onset life-altering diseases, the company's research and development efforts leverage an internal genomics platform and an ongoing collaboration with the Center for Applied Genomics at The Children's Hospital of Philadelphia.